Clinical Scorecard: Meeting the GLP-1 Challenge with High-Resolution Mass Spec

At a Glance

Key Highlights

• HRAM systems like SCIEX ZenoTOF 8600 improve selectivity and sensitivity for peptide analysis.
• Smaller sample volumes and lower limits of quantification (LLOQs) are critical for modern clinical trials.
• The combination of HRAM and triple-quads provides flexibility and efficiency in peptide workflows.

Guideline-Based Recommendations

Diagnosis

• Utilize HRAM for selective quantitative analysis in complex matrices.

Management

• Implement phase-appropriate method design and small-volume workflows.

Monitoring & Follow-up

• Adhere to ICH M10 guidelines for method development and validation.

Risks

• Matrix interferences and the need for intact confirmation can complicate analysis.

Patient & Prescribing Data

Individuals receiving GLP-1 receptor agonist therapies.

Emerging peptide therapeutics require advanced analytical methods to ensure accurate dosing and efficacy.

Clinical Best Practices

• Adopt automated workflows to enhance throughput and reproducibility.
• Employ optimized sample preparation techniques to maximize recovery of peptides.

References

• Veloxity Labs
• SCIEX